Menu Two Labs, an industry-leading pharma services company and part of Envision Pharma Group, today announced that it has acquired Riparian, a pharma consulting and SaaS company that helps manufacturers navigate pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs’ suite of pharma services, allowing the company to provide greater insights around the financials associated with launching and managing a drug, better positioning manufacturers for long-term success. Riparian’s deep understanding of government pricing regulations and program operations – combined with their consulting, business process outsourcing, and software capabilities – enables clients to better understand the financials of their drug, ensuring the prices reported to the government are in compliance with current government statutes and regulations. “Government regulations and reporting requirements are growing increasingly complicated and it’s vital for both emerging and established manufacturers to work with an expert partner during this process,” said Howard Miller, CEO, Two Labs. “Riparian is a quickly growing, innovative company backed by a team of leading industry experts. It’s a privilege to have been selected as their partner by their leadership team.” Riparian and Two Labs will work together to accelerate parent company, Envision Pharma Group’s US expansion plans in the emerging biotech pharma market. Envision acquired Two Labs in November 2020. “This acquisition solidifies our vision to add Two Labs to the Envision family,” said David Thompson, CEO of Envision Pharma Group. “Bringing together Two Labs and Riparian reinforces Envision’s mission to invest in truly transformative organizations, and further expands our capabilities in improving patient access to life-changing medicines.” “Like Two Labs, we’re committed to staying at the forefront of the evolving healthcare market, and we are excited for the growth we can experience by incorporating additional services and subject-matter expertise to meet evolving client needs,” said Riparian Co-Founder and CEO, David Chan. “This partnership elevates the work of both Two Labs and Riparian and creates significant growth potential.” Riparian will continue operating out of their existing headquarters in Henderson, Nevada, with offices in Pasadena, CA and Johnson City, TN. Co-founders David Chan and Cynthia Hwang will remain with the company. Dot grid. Related news View all news Our growing presence in Japan and the Asia-Pacific region News/events Our growing presence in Japan and the Asia-Pacific region August 30, 2017 Envision Pharma Group wins “Best Original Research” prize at ISMPP for the second year running News/events Envision Pharma Group wins “Best Original Research” prize at ISMPP for the second year running August 26, 2017 Envision Pharma Group announces the availability of Scopus citation counts in Datavision News/events Envision Pharma Group announces the availability of Scopus citation counts in Datavision April 24, 2017 Envision announces Altmetric attention data now available in Library™ scientific content management software News/events Envision announces Altmetric attention data now available in Library™ scientific content management software April 24, 2017 Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information News/events Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information March 20, 2017 iEnvision Contact us ISO/IEC 27001 Certification Twitter LinkedIn © 2001-2020 Envision Pharma Group. All rights reserved. Terms of use Privacy notice Cookies notice Privacy shield policy Modern slavery statement We use cookies on our website. By continuing to use this website, you consent to our use of cookies in accordance with our cookie policy. To learn more about cookies, how we use them, and how you can change your settings, please view our Cookies Notice Accept